Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(3)
About
Wockhardt Ltd.
NSE: WOCKPHARMA
|
BSE: 532300
|
ISIN: INE049B01025
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
1918.0000
10.40
(
0.55
%)
NSE
Jun 16, 2026
10:46 AM
76.50% Gain from 52W Low
Volume:
350.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Wockhardt Ltd.
23 May 2017
1918.00
0.55%
Wockhardt Ltd Q4FY17 results comment
Results Update:
Wockhardt Ltd.
by
HDFC Securities
HDFC Securities
Revenue fell by 13.26% to Rs. 863.53 Cr in Q4FY17 when compared to the previous quarter.
Promoters pledged 0.78% of shares in last quarter. Total pledge stands at 18.82% of promoter holdings
More from Wockhardt Ltd.
Recommended
Market trades higher, HCL Technologies invests Rs 1,427 crore in Axonwise
Trendlyne Marketwatch |
16 Jun 2026, 10:37AM
IPO momentum continues with six new issues and three upcoming listings
|
15 Jun 2026, 04:48PM
Earnings Call Transcript - Wockhardt Ltd.
|
03 Feb 2020